02/23/2021 4:17 PM | Esperion Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/23/2021 4:15 PM | Esperion Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/23/2021 3:15 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/11/2021 12:03 PM | Esperion Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/09/2021 1:56 PM | Esperion Therapeutics (Subject) WASATCH ADVISORS INC (Filed by)
| Form SC 13G/A
| |
01/29/2021 4:01 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2021 4:01 PM | Bartram Richard (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2021 4:01 PM | Esperion Therapeutics (Issuer) Hall Ashley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2021 4:00 PM | Esperion Therapeutics (Issuer) Koenig Sheldon L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2021 6:00 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
01/06/2021 1:37 PM | Esperion Therapeutics (Subject) Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
12/31/2020 3:09 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2020 6:36 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2020 6:48 AM | Esperion Therapeutics (Issuer) Koenig Sheldon L. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/15/2020 6:32 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/03/2020 1:36 PM | Esperion Therapeutics (Subject) WASATCH ADVISORS INC (Filed by)
| Form SC 13G
| |
11/16/2020 4:15 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2020 6:01 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2020 3:37 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2020 4:21 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2020 3:28 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2020 4:18 PM | Esperion Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/10/2020 4:16 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/22/2020 7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2020 3:44 PM | Esperion Therapeutics (Subject) MARSHALL WACE, LLP (Filed by)
| Form SC 13G
| |
05/29/2020 3:42 PM | Berkowitz Jeffrey (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2020 3:41 PM | Esperion Therapeutics (Issuer) Fuhrman Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2020 3:32 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2020 4:26 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/20/2020 7:01 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2020 9:34 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/06/2020 6:15 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2020 7:07 AM | Esperion Therapeutics (Issuer) Fuhrman Alan (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2020 7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2020 6:34 AM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/02/2020 5:16 AM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2020 6:30 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2020 4:12 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/27/2020 11:51 AM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2020 7:23 AM | Esperion Therapeutics (Subject) Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
01/03/2020 3:27 PM | Esperion Therapeutics (Issuer) Glickman Mark A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 3:27 PM | Bartram Richard (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 3:27 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2019 1:54 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2019 3:30 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019 7:30 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/06/2019 3:22 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2019 3:09 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2019 3:30 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2019 3:32 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019 7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/25/2019 11:42 AM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2019 3:57 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2019 4:18 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2019 5:09 PM | Esperion Therapeutics (Issuer) VITULLO NICOLE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:52 PM | Esperion Therapeutics (Issuer) Woody Tracy M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:52 PM | Braunstein Scott (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:52 PM | Berkowitz Jeffrey (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:51 PM | Esperion Therapeutics (Issuer) JANNEY DANIEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:51 PM | Esperion Therapeutics (Issuer) GOTTO ANTONIO M JR MD D PHIL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:50 PM | Esperion Therapeutics (Issuer) MCGOVERN MARK E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:50 PM | Esperion Therapeutics (Issuer) Shepard Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2019 3:49 PM | Esperion Therapeutics (Issuer) Woody Tracy M (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/30/2019 3:32 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2019 3:30 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2019 3:32 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019 7:01 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2019 3:30 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2019 3:32 PM | Esperion Therapeutics (Filer)
| Form DEF 14A
| |
04/05/2019 4:23 PM | Bartram Richard (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2019 3:41 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2019 4:01 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2019 8:02 AM | Esperion Therapeutics (Issuer) VITULLO NICOLE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2019 6:50 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2019 3:57 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2019 3:57 PM | Esperion Therapeutics (Issuer) NEWTON ROGER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2019 3:50 PM | Esperion Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2019 3:45 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2019 4:22 PM | Esperion Therapeutics (Subject) Partner Fund Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019 3:30 PM | Esperion Therapeutics (Subject) Pentwater Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/14/2019 10:16 AM | Esperion Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/11/2019 1:17 PM | Esperion Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
01/07/2019 4:10 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2019 6:45 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2019 9:57 AM | Esperion Therapeutics (Subject) Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
12/26/2018 10:44 AM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2018 4:07 PM | Esperion Therapeutics (Issuer) Glickman Mark A (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/21/2018 4:03 PM | Esperion Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/21/2018 4:03 PM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2018 12:14 PM | BB BIOTECH AG (Reporting) BIOTECH TARGET N V (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2018 4:18 PM | Bartram Richard (Reporting) Esperion Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2018 4:17 PM | Esperion Therapeutics (Issuer) Lalwani Narendra D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2018 4:15 PM | Esperion Therapeutics (Issuer) MAYLEBEN TIMOTHY M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2018 6:56 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Esperion Therapeutics (Issuer) LEWIS JOSEPH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2018 4:00 PM | Esperion Therapeutics (Issuer) NEWTON ROGER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2018 3:20 PM | Esperion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018 3:35 PM | Boxer Capital, LLC (Filed by) Esperion Therapeutics (Subject)
| Form SC 13G/A
| |
10/30/2018 3:33 PM | Boxer Asset Management Inc. (Reporting) Boxer Capital, LLC (Reporting) Braslyn Ltd. (Reporting) Esperion Therapeutics (Issuer) LEWIS JOSEPH (Reporting) Tuesday Thirteen Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/29/2018 6:45 AM | Esperion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2018 4:05 PM | Esperion Therapeutics (Issuer) NEWTON ROGER S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |